CJC-1295 & GHRP-2 Blend (10mg)

$84.00

CJC-1295 & GHRP-2 Blend (10mg) is offered by Biotech Peptides for laboratory and analytical research. This reference blend combines CJC-1295 without DAC, a modified GHRH(1-29) analogue, with GHRP-2, a synthetic ghrelin-receptor agonist.

  • Product: CJC-1295 & GHRP-2 Blend

  • Components: CJC-1295 without DAC and GHRP-2

  • Listed quantity: 10 mg

  • Intended use: Laboratory and analytical research only

Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.

For research use only. Not for human consumption.

SKU: CJC-1295-GHRP-2-blend-10mg Category:
Description

CJC-1295 & GHRP-2 Blend (10mg) for Laboratory Research

CJC-1295 & GHRP-2 Blend (10mg) is offered by Biotech Peptides for laboratories investigating growth-hormone secretagogue pathways and pituitary receptor signaling. The reference blend combines CJC-1295 without DAC, a 29-amino-acid modified GHRH(1-29) analogue, with GHRP-2, a six-amino-acid ghrelin-receptor agonist.

For laboratories looking to buy CJC-1295 & GHRP-2 Blend, this listing identifies a 10 mg quantity. Confirm the supplied material’s component identities, blend ratio, sequences, stereochemistry, and analytical characteristics against the requirements of the intended work.

Explore our research peptides for sale to review other laboratory-use listings.

Peptide Blend Product Information

Property Listing information
Product name CJC-1295 & GHRP-2 Blend
Components CJC-1295 without DAC and GHRP-2
Listed quantity 10 mg
Intended application Laboratory and analytical research
Documentation inquiries Include the product name and batch or lot number, where available

The 10 mg designation describes the quantity stated for this listing. It does not independently establish net peptide content, the ratio of the two components, or confirmation that a particular quantity-assay method has been performed.

CJC-1295 Reference Characteristics

The following characteristics describe the CJC-1295 without DAC reference structure. They are not analytical confirmation of an individual commercial batch.

Reference characteristic Information
Peptide length 29 amino acids
Peptide class Modified GHRH(1-29) analogue
Amino-acid sequence Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
One-letter sequence YdADAIFTQSYRKVLAQLSARKLLQDILSR-NH₂
C-terminal group Amide
Molecular formula C₁₅₂H₂₅₂N₄₄O₄₂
Approximate molecular weight 3,367.9 g/mol
PubChem compound identifier 91976842
DAC modification Not present

CJC-1295 without DAC is a tetrasubstituted analogue of the biologically active 29-amino-acid segment of GHRH. The modifications occur at positions 2, 8, 15, and 27. The molecular formula, molecular weight, and compound identifier are documented in the PubChem CJC-1295 Without DAC reference record.pubchem.ncbi.nlm.nih+1

GHRP-2 Reference Characteristics

The following characteristics describe the GHRP-2 reference structure. They are not analytical confirmation of an individual commercial batch.

Reference characteristic Information
Peptide length Six amino acids
Amino-acid sequence D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂
One-letter sequence XAWFK
C-terminal group Amide
Molecular formula C₄₅H₅₅N₉O₆
Approximate molecular weight 817.97 g/mol
PubChem compound identifier 6918245
Alternative name Pralmorelin

GHRP-2 contains D-configured alanine at position 1, D-2-naphthylalanine at position 2, and D-phenylalanine at position 5. The sequence, molecular formula, molecular weight, and terminal-group description are documented

Receptor Pathways in Research

CJC-1295 without DAC is a GHRH analogue and has been studied in relation to GHRH receptor signaling. GHRP-2 is a ghrelin-receptor agonist and has been studied in relation to GHS-R1a signaling.

These are distinct receptor systems. A published review describes GHRH and GHRP-2 as acting through different signaling pathways, with GHRH acting through Gs/cAMP/PKA signaling and GHRP-2 acting through Gq/PLC/IP3/calcium mobilization.

Read the review of GHRH and GHRP-2 synergy for the experimental context of combined exposure.

Synergy Is Context-Dependent

The term “synergy” describes a greater-than-additive response in a particular experimental system. It does not establish that a commercial blend will reproduce the same response in every assay, organism, or exposure condition.

Published research on GHRH and GHRP-2 examines individual compounds and defined exposure conditions. It does not establish that a commercial CJC-1295 without DAC and GHRP-2 blend produces a predictable growth-hormone response in every biological system.pmc.ncbi.nlm.nih+1

Research Limitations

Published research examines growth-hormone secretion, receptor signaling, and specific experimental models. It does not establish that a CJC-1295 without DAC and GHRP-2 blend improves body composition, increases muscle mass, improves bone density, or treats any condition.pmc.ncbi.nlm.nih+1

Published research also does not verify the identity, purity, quantity, component ratio, or biological activity of the commercial batch supplied with this listing.

Documentation and Batch Verification

Before selecting CJC-1295 & GHRP-2 Blend (10mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:

  • Product name and batch or lot identifier.

  • Manufacturer specifications and chemical form.

  • Component identities and blend ratio.

  • Complete sequences and stereochemistry for both components.

  • Counterion information, where applicable.

  • Identity-testing methods and reported results.

  • Purity-testing methods and supporting analytical data.

  • Quantity or peptide-content measurements, where required.

  • Product-specific storage and handling instructions.

Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent names, sequences, ratios, or molecular values.

For inquiries, provide “CJC-1295 & GHRP-2 Blend (10mg),” the batch number where available, and the specific information your laboratory requires.

Storage and Handling

Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.

Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.

Frequently Asked Questions About CJC-1295 & GHRP-2 Blend (10mg)

What is CJC-1295 without DAC?

CJC-1295 without DAC is a 29-amino-acid modified GHRH(1-29) analogue. It does not contain the DAC albumin-binding modification.pubchem.ncbi.nlm.nih+1

What is GHRP-2?

GHRP-2 is a six-amino-acid synthetic peptide, D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂, that acts as a ghrelin-receptor agonist.

Does a blend automatically produce synergistic effects?

No. Synergy is an experimental observation dependent on the specific materials, conditions, and biological system studied.pmc.ncbi.nlm.nih+1

What does the 10mg designation mean?

It is the quantity stated for this listing. It does not describe a concentration or independently establish net peptide content.

Does published research verify this product?

No. Publications describe the materials and conditions used by the investigators. Assess a commercial batch using relevant manufacturer specifications and analytical evidence.

Where can I find delivery information?

Review our shipping information for current order-processing and delivery terms.

Research Use Only

CJC-1295 & GHRP-2 Blend (10mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.

Review our Research-Use-Only Policy before ordering.

Additional information
BrandBiotech Peptides
Shipping & Delivery